TITUSVILLE, N.J., May 24 /PRNewswire/ --New data on INVEGA® SUSTENNA® (paliperidone palmitate), a long-acting injectable medicine for schizophrenia, and new data on RISPERDAL® CONSTA® (risperidone ...
10 February 2004 – Davos – People with schizophrenia treated with RISPERDAL® CONSTA® [risperidone long-acting injection] are significantly less likely to be admitted to hospital than before they were ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. RISPERDAL CONSTA contains the active ingredient risperidone. RISPERDAL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results